Curetis Provides Update on Unyvero LRT FDA 510(k) Submission - Seite 4

Contact details

Curetis
Max-Eyth-Str. 42
71088 Holzgerlingen, Germany
Tel. [phone]
[e-mail] or [e-mail]
www.curetis.com - www.unyvero.com

International Media & Investor Inquiries
akampion
Dr. Ludger Wess / Ines-Regina Buth
Managing Partners
info(@)akampion.com
Tel. [phone]
Tel. [phone]

U.S. Media & Investor Inquiries
The Ruth Group
Lee Roth
[e-mail]
Tel. [phone]

Curetis_Logo
20170524_Curetis_PR_EN_FDA Update

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Curetis via Globenewswire

--- End of Message ---

Curetis
Max-Eyth-Str. 42 Holzgerlingen Germany


Listed: Open Market (Freiverkehr) in Frankfurter Wertpapierbörse;